Pre-order Enquiry
Request Free Sample
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2022-2028
SKU ID : LPI-19886730 | Publishing Date : 06-Jan-2022 | No. of pages : 73
Detailed TOC of Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2022-2028
1 Scope of the Report1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for 23-Valent Pneumococcal Polysaccharide Vaccine by Country/Region, 2017, 2022 & 2028
2.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2017-2022)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
2.4.1 For Children (2-10)
2.4.2 For Person (10-64)
2.4.3 For The Old (Above or equal to 65)
2.5 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
2.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2017-2022)
3 Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Breakdown Data by Company
3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2020-2022)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2020-2022)
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company
3.4 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Location Distribution
3.4.2 Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Region
4.1 World Historic 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Geographic Region
4.2 World Historic 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Country/Region
4.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.4 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.5 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.6 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
5 Americas
5.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
5.1.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022)
5.1.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022)
5.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
5.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
6.1.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022)
6.1.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2022)
6.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
6.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Country
7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022)
7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022)
7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Country
8.1.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
8.3 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
10.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
10.4 Industry Chain Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
11.3 23-Valent Pneumococcal Polysaccharide Vaccine Customer
12 World Forecast Review for 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Region
12.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Region
12.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Region (2023-2028)
12.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Type
12.7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Application
13 Key Players Analysis
13.1 MSD
13.1.1 MSD Company Information
13.1.2 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
13.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 MSD Main Business Overview
13.1.5 MSD Latest Developments
13.2 Sanofipasteur
13.2.1 Sanofipasteur Company Information
13.2.2 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
13.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofipasteur Main Business Overview
13.2.5 Sanofipasteur Latest Developments
13.3 CDIBP
13.3.1 CDIBP Company Information
13.3.2 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
13.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CDIBP Main Business Overview
13.3.5 CDIBP Latest Developments
14 Research Findings and Conclusion
List of Figures, Tables and Charts Available in Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2022-2028
List of TablesTable 1. 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Single Dose Vial
Table 4. Major Players of Pre-filled Syringe
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2017-2022) & (US$/Dose)
Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2017-2022) & (US$/Dose)
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2020-2022) & (K Dose)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company (2020-2022) & (US$/Dose)
Table 20. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution and Sales Area
Table 21. Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
Table 22. 23-Valent Pneumococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Region (2017-2022) & (K Dose)
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country/Region (2017-2022) & (K Dose)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
Table 34. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 38. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 40. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Dose)
Table 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 46. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 48. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
Table 50. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 54. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 56. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
Table 58. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 62. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 64. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 66. Key Market Challenges & Risks of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 67. Key Industry Trends of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 68. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 71. 23-Valent Pneumococcal Polysaccharide Vaccine Customer List
Table 72. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2023-2028) & (K Dose)
Table 73. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Forecast by Region
Table 74. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Dose)
Table 77. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2023-2028) & (K Dose)
Table 79. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Dose)
Table 81. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Dose)
Table 83. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2023-2028) & (K Dose)
Table 85. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2023-2028) & (K Dose)
Table 89. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. MSD Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 94. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 95. MSD Main Business
Table 96. MSD Latest Developments
Table 97. Sanofipasteur Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 99. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 100. Sanofipasteur Main Business
Table 101. Sanofipasteur Latest Developments
Table 102. CDIBP Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 104. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 105. CDIBP Main Business
Table 106. CDIBP Latest Developments
List of Figures
Figure 1. Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2017-2028 (K Dose)
Figure 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Single Dose Vial
Figure 10. Product Picture of Pre-filled Syringe
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2021
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Children (2-10)
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Children (2-10) (2017-2022) & (K Dose)
Figure 15. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Person (10-64)
Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Person (10-64) (2017-2022) & (K Dose)
Figure 17. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For The Old (Above or equal to 65)
Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For The Old (Above or equal to 65) (2017-2022) & (K Dose)
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2021
Figure 21. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company in 2021
Figure 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region in 2021
Figure 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Figure 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country/Region in 2021
Figure 27. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2022 (K Dose)
Figure 28. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2022 (K Dose)
Figure 30. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2022 (K Dose)
Figure 32. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2022 (K Dose)
Figure 34. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2021
Figure 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021
Figure 37. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2021
Figure 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2021
Figure 43. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2021
Figure 50. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021
Figure 51. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021
Figure 58. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine in 2021
Figure 64. Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 65. Industry Chain Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Request Sample
Request Discount
